Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AEON Biopharma, Inc. Class A Common Stock (NY:AEON)

0.9200 +0.0300 (+3.37%)
Streaming Delayed Price Updated: 12:26 PM EDT, Apr 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about AEON Biopharma, Inc. Class A Common Stock

< Previous 1 2 3 Next >
News headline image
Top movers in Monday's session ↗
Intrigued by the market activity one hour before the close of the markets on Monday? Uncover the key winners and losers of today's session in our insightful analysis. 
Via Chartmill
News headline image
Wondering what's happening in today's after-hours session? ↗
The US market regular session of Friday is over, let's have a look at the top gainers and losers in the after hours session today. 
Via Chartmill
News headline image
Retail Traders Flocked To These 5 Biotech Stocks In January — Here’s Why ↗
Biotech remains a high-risk, high-reward sector, and this month’s top draws reflect retail’s appetite for stocks with major clinical and regulatory catalysts. 
Via Stocktwits
News headline image
Kairos, OS Therapies, AEON See Highest Weekly Spike In Retail Following Among Biotechs: Here's Why ↗
Cancer treatments, FDA breakthroughs, and other developments fueled a sharp spike in interest for these biotech players, as investors bet on promising clinical data and strategic moves. 
Via Stocktwits
News headline image
Why AEON Biopharma Stock Is Down 65% Today ↗
AEON Biopharma shares are trading lower by 65% during Monday's session. The company announced the pricing of a $20 million offering. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Dow Jumps Over 300 Points; US Industrial Production Beats Estimates ↗
 
Via Benzinga
Topics Stocks
News headline image
Why Taiwan Semiconductor Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
InvestorNewsBreaks – AEON Biopharma Inc. (NYSE: AEON) Secures $20M in Underwritten Public Offering
Via Investor Brand Network
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Nasdaq Surges Over 200 Points; BioLineRx Shares Plummet ↗
 
Via Benzinga
News headline image
S&P Jumps 1%; Regional Health Properties Shares Spike Higher ↗
 
Via Benzinga
Topics Stocks
News headline image
US Stocks Open Higher; Dow Jumps Over 200 Points ↗
 
Via Benzinga
Topics Stocks
News headline image
Why Smart Share Global Shares Are Trading Higher By 44%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
AEON Stock Earnings: AEON Biopharma Beats EPS for Q2 2024 ↗
AEON stock results show that AEON Biopharma beat analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
News headline image
Why Charles Schwab Shares Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗
It's time to dive into the biggest pre-market stock movers as we check out all of the latest news worth reading about on Tuesday morning! 
Via InvestorPlace
News headline image
Why Match Group Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Why SolarEdge Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
AEON Stock Earnings: AEON Biopharma Misses EPS for Q1 2024 ↗
AEON stock results show that AEON Biopharma missed analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
News headline image
S&P 500 Rises Over 1%; Hershey Earnings Top Views ↗
 
Via Benzinga
Topics Stocks
News headline image
Newly Listed Migraine-Focused AEON Biopharma Stock Plunges On Friday - Read Here Why ↗
Preliminary results of AEON Biopharma's Phase 2 trial for chronic migraine treatment reveal no significant improvement over placebo. Despite anticipated reductions in monthly migraine days, statistical... 
Via Benzinga
News headline image
Nasdaq Surges 2%; Apple Posts Upbeat Results ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
Dow Jumps Over 400 Points; US Adds 175,000 Jobs In April ↗
 
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.